… Grants awarded through four spring 2018 funding programs to advance top Parkinson's research priorities Funding will … at academic centers and biotechnology and pharmaceutical companies across 12 countries NEW YORK (June 27, 2018) -- … for the spring 2019 funding round later this summer. Visit www.michaeljfox.org/funding for more information on …

… run 13.1 miles in a decent time. I ultimately would love to beat my time last year, but I'm not going to push it. I find if I don't think about running while I'm … talking about it? It's the craziest feeling. I ran 3 miles without stopping and even ran a little faster than usual. So …

… results in costly delays and even cancelling studies altogether. This kind of breakdown in the research process … needed for a study, someone would have asked them. This is where making sure that people understand their range of options and their rights as a subject comes in. We call it "demystifying clinical trials" and …

… message I'd have for anybody is sleep and the ability to sleep is probably the most important aspect of treating … of neurology at Harvard Medical School discuss sleep issues common in Parkinson's disease in this Third Thursdays Webinar. Topics covered during the hour include:   Are sleep issues a …

… more alpha-synuclein in the skin of PD patients (right) compared to controls. Image courtesy of Neurology. Alpha-synuclein … is our most promising target for a drug that could stop or prevent Parkinson’s,” said Todd Sherer, PhD, MJFF CEO. …

… Increasing evidence suggests that the disorder we refer to as Parkinson’s disease (PD) might represent several diseases, each driven by different … the mitochondria’s genetic material, called mitochondrial DNA. We will then group our study population according to …